Skip to main content

Table 3 Clinical and Amplicor result status comparison between baseline and follow-up for children present at both time-points

From: Impact of a single round of mass drug administration with azithromycin on active trachoma and ocular Chlamydia trachomatis prevalence and circulating strains in The Gambia and Senegal

 

Active trachoma (TF and/or TI)

Amplicor-negative at both time-points

Amplicor-positive at both time-points

Amplicor-positive at baseline only

Amplicor-positive at follow-up only

Total

The Gambia

No active trachoma at either time-point

552

0

6

13

571

Active trachoma at both time-points

68

6

1

7

82

Active trachoma at baseline only

114

0

13

1

128

Active trachoma at follow-up only

58

1

1

6

66

Total

792

7

21

27

847

Senegal

No active trachoma at either time-point

995

0

4

14

1013

Active trachoma at both time-points

38

5

1

9

53

Active trachoma at baseline only

141

0

16

0

157

Active trachoma at follow-up only

39

0

0

20

59

Total

1213

5

21

43

1282